BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20217579)

  • 1. HELP (HpaII tiny fragment enrichment by ligation-mediated PCR) assay for DNA methylation profiling of primary normal and malignant B lymphocytes.
    Shaknovich R; Figueroa ME; Melnick A
    Methods Mol Biol; 2010; 632():191-201. PubMed ID: 20217579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide determination of DNA methylation by Hpa II tiny fragment enrichment by ligation-mediated PCR (HELP) for the study of acute leukemias.
    Figueroa ME; Melnick A; Greally JM
    Methods Mol Biol; 2009; 538():395-407. PubMed ID: 19277580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HELP assay.
    Oda M; Greally JM
    Methods Mol Biol; 2009; 507():77-87. PubMed ID: 18987808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide profiling of promoter methylation in human.
    Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
    Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation profiling using HpaII tiny fragment enrichment by ligation-mediated PCR (HELP).
    Suzuki M; Greally JM
    Methods; 2010 Nov; 52(3):218-22. PubMed ID: 20434563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative DNA methylation profiling on a high-density oligonucleotide microarray.
    Fassbender A; Lewin J; König T; Rujan T; Pelet C; Lesche R; Distler J; Schuster M
    Methods Mol Biol; 2010; 576():155-70. PubMed ID: 19882262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
    Tryndyak V; Kovalchuk O; Pogribny IP
    Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspective of DNA methylation in forensic genetics and new progress of its detection methods].
    Zhao SM; Li CT
    Fa Yi Xue Za Zhi; 2009 Aug; 25(4):290-5. PubMed ID: 19788082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time PCR-based assay for quantitative determination of methylation status.
    Lehmann U; Kreipe H
    Methods Mol Biol; 2004; 287():207-18. PubMed ID: 15273414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PCR-based method for studying DNA methylation.
    Ariel M
    Methods Mol Biol; 2001; 181():205-16. PubMed ID: 12843452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells.
    Vertino PM; Spillare EA; Harris CC; Baylin SB
    Cancer Res; 1993 Apr; 53(7):1684-9. PubMed ID: 8453642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer.
    Eilertsen KJ; Power RA; Harkins LL; Misica P
    Anim Reprod Sci; 2007 Mar; 98(1-2):129-46. PubMed ID: 17166676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific extension on microarray for DNA methylation analysis.
    Wu Z; Luo J; Ge Q; Zhang D; Wang Y; Jia C; Lu Z
    Anal Chim Acta; 2007 Nov; 603(2):199-204. PubMed ID: 17963840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
    Schroeder M; Mass MJ
    Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental manipulation of genomic methylation.
    Jackson-Grusby L; Jaenisch R
    Semin Cancer Biol; 1996 Oct; 7(5):261-8. PubMed ID: 9110403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines.
    Grafodatskaya D; Choufani S; Ferreira JC; Butcher DT; Lou Y; Zhao C; Scherer SW; Weksberg R
    Genomics; 2010 Feb; 95(2):73-83. PubMed ID: 20005943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray-based method to analyze methylation status of E-cadherin gene in leukemia.
    Zheng W; Wang Y; Luo J; Zhang F; Chen B; Lu Z
    Clin Chim Acta; 2008 Jan; 387(1-2):97-104. PubMed ID: 17964562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells.
    Park JJ; Kang JK; Hong S; Ryu ES; Kim JI; Lee JH; Seo JS
    Gene; 2008 Jan; 407(1-2):139-47. PubMed ID: 17997235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.